Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron supplementation protocols with enarodustat in hemodialysis patients with renal anemia
ChiCTR2400083227Phase 4Not yet recruiting
- Sponsor
- Department of Nephrology, Peking University First Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of enarodustat in anemia of renal disease (3 arms), sponsored by Department of Nephrology, Peking University First Hospital. Primary endpoint: Hb/AAD (hemoglobin to enarodustat dose efficiency ratio). Planned start Apr 2024; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR2400083227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083227.